Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil

NCT02946125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Mydriasis

Interventions

COMBINATION_PRODUCT: MDD-administered EYN-1601
DRUG: Phenylephrine 2.5% Eyedrop
DRUG: Phenylephrine 10% Eyedrop

Sponsor

Eyenovia Inc.